254 related articles for article (PubMed ID: 22792172)
1. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.
Jarajapu YP; Cai J; Yan Y; Li Calzi S; Kielczewski JL; Hu P; Shaw LC; Firth SM; Chan-Ling T; Boulton ME; Baxter RC; Grant MB
PLoS One; 2012; 7(7):e39398. PubMed ID: 22792172
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.
Kielczewski JL; Jarajapu YP; McFarland EL; Cai J; Afzal A; Li Calzi S; Chang KH; Lydic T; Shaw LC; Busik J; Hughes J; Cardounel AJ; Wilson K; Lyons TJ; Boulton ME; Mames RN; Chan-Ling T; Grant MB
Circ Res; 2009 Oct; 105(9):897-905. PubMed ID: 19762684
[TBL] [Abstract][Full Text] [Related]
3. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
[TBL] [Abstract][Full Text] [Related]
4. IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels.
Zhang Q; Jiang Y; Steinle JJ
Mol Vis; 2015; 21():604-11. PubMed ID: 26015772
[TBL] [Abstract][Full Text] [Related]
5. Insulin stabilizes microvascular endothelial barrier function via phosphatidylinositol 3-kinase/Akt-mediated Rac1 activation.
Gündüz D; Thom J; Hussain I; Lopez D; Härtel FV; Erdogan A; Grebe M; Sedding D; Piper HM; Tillmanns H; Noll T; Aslam M
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1237-45. PubMed ID: 20339116
[TBL] [Abstract][Full Text] [Related]
6. Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase.
Katakam PV; Wappler EA; Katz PS; Rutkai I; Institoris A; Domoki F; Gáspár T; Grovenburg SM; Snipes JA; Busija DW
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):752-9. PubMed ID: 23329133
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
10. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
11. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
12. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
13. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity.
Liu X; Wang B; Sun Y; Jia Y; Xu Z
Cell Cycle; 2019 Nov; 18(22):3147-3159. PubMed ID: 31564208
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of insulin-like growth factor binding protein-related protein 1 on retinal angiogenesis via ERK signaling pathway].
Zhang P; Wang H; Cao H; Xu X; Sun T
Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):207-211. PubMed ID: 28316197
[No Abstract] [Full Text] [Related]
17. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH; Zhao K
Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
19. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.
Cho YL; Hur SM; Kim JY; Kim JH; Lee DK; Choe J; Won MH; Ha KS; Jeoung D; Han S; Ryoo S; Lee H; Min JK; Kwon YG; Kim DH; Kim YM
J Biol Chem; 2015 Jan; 290(1):467-77. PubMed ID: 25391655
[TBL] [Abstract][Full Text] [Related]
20. Silencing Nogo-B improves the integrity of blood-retinal barrier in diabetic retinopathy via regulating Src, PI3K/Akt and ERK pathways.
Yang Q; Zhang C; Xie H; Tang L; Liu D; Qiu Q; Luo D; Liu K; Xu JY; Tian H; Lu L; Xu GT; Zhang J
Biochem Biophys Res Commun; 2021 Dec; 581():96-102. PubMed ID: 34662809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
